Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eeseCfbwoceYahrpgjQt

  ADVERTISEMENT  
January 8, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
 
  • N.Y. to implement guidelines for identifying, treating sepsis
    New York Gov. Andrew M. Cuomo will instruct hospitals in the state to implement aggressive measures for diagnosing sepsis in patients, including the use of a countdown-to-treatment protocol, according to a state official. The Society of Critical Care Medicine plans to release updated guidelines in January, and Cuomo is expected to call for hospitals to use a protocol that "aligns with proven best practices" as part of his State of the State address. The New York Times (tiered subscription model) (1/7) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Empower the miracles of cell therapy.
Mediware's Transtem software is enabling cord blood banks, cellular therapy labs and transplant centers with the tools to more effectively manage stem cell products from collection to utilization. Access product information and request an online demonstration to learn how Transtem can support your needs.

  Science & Health 
  • Major laparoscopic hepatectomy comparable with open liver resection
    Outcomes for three types of laparoscopic major hepatectomy were comparable with those for standard open liver resection, according to findings from a literature review published in the Annals of Surgery. Blood loss was limited in laparoscopic liver surgery and the mortality rate was low due in part to careful dissection and pressure from the pneumoperitoneum, a researcher said. Living donor resections seemed safe, but only 87 cases were reviewed. Medscape (free registration)/Reuters (1/3) LinkedInFacebookTwitterEmail this Story
 
  • Study rejects link between flu vaccine, epilepsy seizure risk
    Researchers looked at data from a vaccination database in Sweden and found that epilepsy patients who received the H1N1 flu vaccine Pandemrix were at no greater risk of suffering from seizures. The study, which involved 373,398 people, appeared in the British Medical Journal. DailyRx.com (1/4) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Digi-Trax® is your source for ISBT 128 labels
For labels that withstand the rigors of blood banking, look to our large selection of stock labels that meet FDA requirements for durability and readability. We have label materials for every budget. Need a unique label? We produce custom labels and offer on-demand printing solutions. And, as a full service provider, we provide validation services if needed. Learn more.

  Emerging Trends 
  • Cuts to medical research funding will stall progress and waste money
    Congress postponed until March deep budget cuts that had been due to take effect at the start of this year. If these cuts to the NIH, FDA, CDC and other agencies are allowed to happen, promising projects will stall, people will needlessly suffer and jobs will be lost, three medical school deans write. "A strong America requires investments that protect our economy and our health," they write. The Washington Post (1/6) LinkedInFacebookTwitterEmail this Story
 
  Industry News & Practice 
  • FDA OKs trial of Terumo protocol for polymorphonuclear cells
    The FDA has approved a trial to assess a collection protocol for polymorphonuclear cells using the Spectra Optia platform, according to Terumo BCT. Polymorphonuclear cells from donors could help patients whose immune systems are compromised due to illness or chemotherapy. InnovatioNews (1/7) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • ONC seeks members of 2 HIT workgroups
    Applications are being accepted by the Office of the National Coordinator for Health IT for possible members of the Health IT Policy Committee's Consumer Empowerment Workgroup and Health IT Standards Committee's Consumer Technology Workgroup. The workgroups, which were created to help consumers and patients understand the benefits of EHRs, have an application deadline of Jan. 14. Healthcare Informatics online (1/4) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Revised 6th edition of "Standards for Cellular Therapies" is available for public comment
    The sixth edition of "Standards for Cellular Therapies" once again is available for public comment. This second comment period is being held to provide members with an opportunity to review new standards that have been added to the document since it was last released in August. The new standards — which are highlighted in an accompanying summary of changes — complete the expansion of the CT Standards into clinical activities related to patient care. The 30-day comment period will conclude on Jan. 14. AABB's Cellular Therapy Standards Program Unit encourages all interested individuals to submit comments during this time. The draft document and instructions on how to submit comments are available online. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Clinical Lab Specialist IICreative Testing SolutionsUS - FL - St. Petersburg
Director of Quality SystemsRock River Valley Blood CenterUS - IL - Rockford
Performance Improvement ConsultantBlood Systems, Inc.US - AZ - Scottsdale
DIRECTOR, COMMUNITY CENTER IUnited Blood ServicesUS - NV - Reno
QA SpecialistSan Diego Blood BankUS - CA
Reference TechnologistLifeStreamUS - CA - San Bernardino
Click here to view more job listings.

  SmartQuote 
It is wise to keep in mind that neither success nor failure is ever final."
--Roger Babson,
American entrepreneur and business theorist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information